© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Melphalan Hydrochloride stands among important alkylating agents, recognized for its role in the treatment of various cancers, including multiple myeloma and ovarian carcinoma. Chemically, Melphalan Hydrochloride shows a strong presence as a synthetic derivative of nitrogen mustard. This compound forms when melphalan reacts with hydrochloric acid, producing a more stable and water-soluble salt with unique properties.
Most users encounter Melphalan Hydrochloride in solid form—typically as small, off-white to pale yellow flakes, powder, or crystalline pearls. These physical forms show ease of measurement and precision when preparing intravenous or oral pharmaceutical solutions. Melphalan Hydrochloride does not display notable odor and can clump slightly under humid conditions, so storage in dry, tightly sealed conditions helps maintain its consistency. Its crystalline structure offers increased solubility in water compared to basic melphalan, which supports its use in both laboratory and clinical settings. The solid material, whether packed in grams or kilograms, aligns strictly with pharmaceutical and chemical raw material standards.
Chemically, Melphalan Hydrochloride holds the molecular formula C13H18Cl2N2O2. As for molecular weight, this compound measures approximately 305.21 g/mol. Its structure features a bis(2-chloroethyl)amine group attached to a phenylalanine backbone, allowing it to interact directly with DNA within target cells. Usually, the density measures about 1.5 g/cm³ at room temperature. Every batch targets specification for purity and molecular property through rigorous testing—pharmacopoeia standards demand high chemical identity and confirm absence of unwanted contaminants.
Meeting global trade and customs requirements, Melphalan Hydrochloride holds the Harmonized System (HS) code 2934999099 (subject to regional updates). Specifications range according to intended use, but general requirements include purity exceeding 98%, low levels of moisture, and compliance with impurity thresholds. Powder and crystalline material both fall under controlled substances, prompting strict documentation during shipment and usage. Each shipment documents lot number, batch size, certificate of analysis, and molecular characteristics, providing end users and regulators the traceability needed.
Melphalan Hydrochloride forms as a stable, non-volatile powder at ambient temperatures. Manufacturers process this compound to yield high flow characteristics in powder, granule, or micro-pearls, making it straightforward to dissolve in water or buffered saline. In solution, Melphalan Hydrochloride shows a clear or faintly opalescent liquid, as high purity ensures minimal visible particulate contamination. The melting point usually falls in the range of 177–182 °C. High-grade pharmaceutical Melphalan Hydrochloride exhibits pH values from 3.0 to 5.0 in aqueous solutions, compatible with biological fluids. Standard packing might range from sealed glass ampoules for solution to double-layer safe bags for bulk powder.
This compound dissolves easily in water, yielding a stable and bioavailable solution favored for intravenous and oral medication. Its solubility in water rises above 3 mg/ml, supporting reliable drug compounding. Melphalan Hydrochloride does not dissolve efficiently in nonpolar solvents, so water-based handling is standard. Proper storage extends its shelf life—typical instructions call for temperatures below 25 °C, avoidance of excessive humidity, and protection from direct light. Decomposition may release hydrochloric acid vapors and other harmful byproducts, so containment and ventilation carry significant importance.
Working with Melphalan Hydrochloride means acknowledging its hazardous profile. Classified as acutely toxic, it can damage DNA and presents carcinogenic potential with prolonged exposure. Direct skin or eye contact may lead to burns, rash, and irritation. Inhalation or accidental ingestion carries significant health risks, so laboratories and pharmaceutical plants train personnel to use gloves, safety goggles, and dust masks when handling powder or preparing solutions. Medical material safety data sheets (MSDS) guide all work—spills must be handled with certified kits, and contaminated clothing removed quickly. Disposal of raw materials and solutions demands compliance with local regulations and must mitigate risk to both workers and communities.
Serving as a raw material in oncology pharmaceuticals, Melphalan Hydrochloride’s impact reaches far beyond basic active ingredient supply. Its molecular structure forms the bedrock for several drug formulations, where quality and stability remain linked to successful patient outcomes. Sourcing authenticated, properly characterized lots makes all the difference in ensuring each vial or tablet meets clinical safety and effectiveness requirements. Producers and contractors work closely with accredited suppliers, who guarantee consistent appearance, density, and chemical identity batch to batch. Through ongoing innovation—better packaging, improved synthesis, stricter environmental controls—the broader industry pushes to reduce hazardous waste and increase operator safety. High transparency between supplier and user helps prevent errors, avoid cross-contamination, and maintain the integrity needed in the world’s hospitals and research clinics.
Use of Melphalan Hydrochloride in industrial and pharmaceutical contexts brings challenges involving human health, environmental exposure, and regulatory compliance. My own experience in pharmaceutical environments shows that vigilance at every stage helps lower risks: workers undergo routine training, chemical hygiene plans update with the latest safety data, and emergency protocols remain visible and practiced. Automation in dosing and packaging lines cuts down on manual intervention, limiting accidental release. Engineering controls such as clean rooms, sealed transfer systems, and point source ventilation further protect both staff and material. Digitally tracked chain-of-custody systems prove valuable in managing logistics, minimizing theft or misuse. To continue safeguarding people, communities, and the environment, companies and researchers invest in greener synthesis, safer surfactants, and more robust containment—demonstrating that while Melphalan Hydrochloride remains crucial, constant vigilance keeps its power aligned with the public good.
